Anifrolumab and Dermatomyositis
收藏Mendeley Data2026-04-09 收录
官方服务：
资源简介：
The purpose of this systematic review was to evaluate the potential of anifrolumab as a novel treatment for dermatomyositis. We searched the PubMed, Embase, and Cochrane libraries for articles related to anifrolumab and dermatomyositis. Of the 50 articles screened, six met the criteria for inclusion (Figure 1). The 2009 Oxford levels of evidence were used to evaluate the quality of all articles included (Mendeley supplementary table 1).
